Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread
- 19 June 2013
- journal article
- review article
- Published by Elsevier BV in Microbes and Infection
- Vol. 15 (8-9), 625-629
- https://doi.org/10.1016/j.micinf.2013.06.003
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS CoronavirusmBio, 2013
- Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic PotentialmBio, 2013
- Into the Eye of the Cytokine StormMicrobiology and Molecular Biology Reviews, 2012
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon ChallengeJournal of Virology, 2011
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging InfectionClinical Microbiology Reviews, 2007
- Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike VariantsPLoS Medicine, 2006
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Novel Therapies Based on Mechanisms of HIV-1 Cell EntryThe New England Journal of Medicine, 2003
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences of the United States of America, 1994